Cargando…

A cross‐sectional study of patients referred for HNF1B‐MODY genetic testing due to cystic kidneys and diabetes

BACKGROUND/OBJECTIVES: Patients referred for HNF1B testing present very heterogeneous phenotypes. Despite suggestive characteristics, many do not harbor mutations in HNF1B. Our objective was to evaluate the clinical characteristics of probands referred for HNF1B genetic testing through a nationwide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sztromwasser, Paweł, Michalak, Arkadiusz, Małachowska, Beata, Młudzik, Paulina, Antosik, Karolina, Hogendorf, Anna, Zmysłowska, Agnieszka, Borowiec, Maciej, Młynarski, Wojciech, Fendler, Wojciech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons A/S 2020
Materias:	Monogenic Diabetes and Other Genetic Disorders of Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217165/ https://www.ncbi.nlm.nih.gov/pubmed/31825128 http://dx.doi.org/10.1111/pedi.12959

Ejemplares similares

Pancreatic beta‐cell function dynamics in youth with GCK , HNF1A , and KCNJ11 genes mutations during mixed meal tolerance test
por: Stankute, Ingrida, et al.
Publicado: (2022)

SAT085 Oral Glucagon-like Peptide-1 Receptor Agonist As Adjuvant Treatment In HNF1A-MODY
por: Tyler Broome, David
Publicado: (2023)

Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level
por: Fendler, Wojciech, et al.
Publicado: (2014)

SAT086 Early-onset HNF1B-MODY With Persistent Insulin Requirement In A 2-year-old Female
por: Ighalo, Fulfilled, et al.
Publicado: (2023)

PSUN269 Suboptimal Sulfonylurea Therapeutic Response in a Patient with MODY-3 with a Rare HNF1A Pathogenic Genetic Variant
por: Villavicencio, Camila, et al.
Publicado: (2022)

OR34-06 Gliclazide Restores Appropriate Glucagon Suppression During OGTT In MODY3 & MODY1 Patients: Results Of The “Glucagon In MODY” Study
por: Spiliotis, Ioannis Ilias, et al.
Publicado: (2023)

MON-646 Novel Use of GLP-1 Receptor Agonist Therapy in MODY-1 (HNF4A Mutation)
por: Broome, David Tyler, et al.
Publicado: (2020)

SUN-129 Early Onset Of MODY 5 Due To The Haploinsufficency HNF1B Gene As Part Of 17q12 Deletion
por: Bustamante Escobar, Carmen, et al.
Publicado: (2019)

FRI637 Missed MODY With Complex Mutation
por: Bulchandani, Sheetal, et al.
Publicado: (2023)

Increased referrals for congenital hyperinsulinism genetic testing in children with trisomy 21 reflects the high burden of non‐genetic risk factors in this group
por: Hewat, Thomas I., et al.
Publicado: (2022)

MON-130 Optimal Glycemic Control in a Patient with HNF1A MODY with GLP1-RA Monotherapy: Implications for Future Therapy
por: Fantasia, Kathryn, et al.
Publicado: (2019)

PSUN247 Unique Presentation of MODY Type 5
por: Bella, Sama, et al.
Publicado: (2022)

ODP186 Difficulties in diagnosing MODY: clinical case
por: Volkova, Natalya, et al.
Publicado: (2022)

Central Nervous System PET-CT Imaging Reveals Regional Impairments in Pediatric Patients with Wolfram Syndrome
por: Zmyslowska, Agnieszka, et al.
Publicado: (2014)

Elevated level of lysophosphatidic acid among patients with HNF1B mutations and its role in RCAD syndrome: a multiomic study
por: Małachowska, Beata, et al.
Publicado: (2022)

Next-Generation Sequencing in the Diagnosis of Patients with Bardet–Biedl Syndrome—New Variants and Relationship with Hyperglycemia and Insulin Resistance
por: Jeziorny, Krzysztof, et al.
Publicado: (2020)

SAT082 Utility Of A MODY Probability Calculator As A Systemwide Surveillance Tool
por: Awad, Dana, et al.
Publicado: (2023)

SAT079 A Novel Variant In The Carboxyl Ester Lipase (CEL) Gene Causing MODY
por: Medavarapu, chalapathi Rao, et al.
Publicado: (2023)

SAT078 A Case Of MODY Due To A Rare Activating Variant In The ABCC8 Gene
por: Milosavljevic, Jovan, et al.
Publicado: (2023)

SAT081 Maturity Onset Diabetes Of The Young (MODY) Due To A New BLK Gene Mutation
por: Taha, Doris, et al.
Publicado: (2023)

ODP255 Woman With Maturity-Onset Diabetes of the Young Type 2 (MODY2) Mistakenly Diagnosed and Treated as Type 2 Diabetes Mellitus
por: Nacache, Deborah Sasha Bernardes, et al.
Publicado: (2022)

LBODP032 Case Report Of A 13 Years Old Female With A Novel Pathogenic Variant In The Hnf1b Gene
por: Griffing, Emily, et al.
Publicado: (2022)

Circulating ghrelin level is higher in HNF1A–MODY and GCK–MODY than in polygenic forms of diabetes mellitus
por: Nowak, Natalia, et al.
Publicado: (2015)

SUN-687 MODY-14: A Rare Cause of Inherited Diabetes
por: Epp, Riley, et al.
Publicado: (2020)

LBODP052 A Novel Hnf4α Corepressor Irf2bp2: Its Role In The Gluconeogenic Gene Regulation Via Biochemically Labile Interaction
por: Kouketsu, Takumi, et al.
Publicado: (2022)

Single patient in GCK-MODY family successfully re-diagnosed into GCK-PNDM through targeted next-generation sequencing technology
por: Antosik, Karolina, et al.
Publicado: (2015)

Influence of IGF2BP2, HMG20A, and HNF1B genetic polymorphisms on the susceptibility to Type 2 diabetes mellitus in Chinese Han population
por: Huang, Ting, et al.
Publicado: (2020)

SUN-130 A Not-So-Simple Work-Up of Diabetes: A Case of MODY 5
por: Tran, Trung, et al.
Publicado: (2019)

SAT038 Dietary Trans-10,cis-12 Conjugated Linoleic Acid Regulates Glucose Levels In Mice With Severe Insulin Resistance: Potential Effects On The Liver Via HNF4α And FOX01
por: Man Lee, Samuel, et al.
Publicado: (2023)

SUN-690 HNF4A Mutation in Siblings with Diazoxide Responsive Congenital Hyperinsulinism
por: Erkin-Cakmak, Ayca, et al.
Publicado: (2020)

SAT165 A Novel Mutation In The HNF4α Gene (C.691C>T, P.arg231trp) Likely To Be Pathogenic For Maturity Onset Diabetes Of The Young Type 1 Presenting With Hyperinsulinemic Hypoglycemia In An Infant
por: Rodriguez, Adriana, et al.
Publicado: (2023)

SUN-132 Investigating the Accuracy of Risk Factor Calculators in Diagnosing Maturity Onset Diabetes of the Young (MODY)
por: McCarthy, Aisling, et al.
Publicado: (2019)

MON-LB120 MODY3 With Insulin Coding Gene Mutation and Craniofacial Microsomia: A Case Report
por: Cao, Chenxiang, et al.
Publicado: (2020)

Phenotype variability and neonatal diabetes in a large family with heterozygous mutation of the glucokinase gene
por: Borowiec, Maciej, et al.
Publicado: (2011)

SUN-LB035 Blood Glucose Trends Documented by Continuous Glucose Monitors Can Be Foundational in the Diagnostic Evaluation of MODY 2
por: Addala, Ananta, et al.
Publicado: (2019)

Sodium Glucose Co-Transporter2 (SGLT2) Inhibition for Refractory Hypomagnesemia in Monogenic Diabetes Type 5 (MODY 5)
por: Paul, Anju A, et al.
Publicado: (2021)

SAT-162 Hepatocyte Nuclear Factor-4α (HNF44α) as a Target to Treat DM
por: Jorge dos Santos, Gustavo, et al.
Publicado: (2019)

SUN-128 Novel Mutation in the HNF1A Gene in Siblings Previously Diagnosed with Type 1 Diabetes
por: Raisingani, Manish, et al.
Publicado: (2019)

SUN-LB119 Role of HNF4a Isoforms in the Carbohydrate/Lipid Switch in the Liver and Responsiveness to AMPK
por: Radi, Sarah, et al.
Publicado: (2020)

Retinal thickness as a marker of disease progression in longitudinal observation of patients with Wolfram syndrome
por: Zmyslowska, Agnieszka, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lshu49jjevk6k465gm4l7vve8s